Bone Resorption Assay Plate 使用論文
1) Kim JL, Osteogenic activity of yellow flag iris (Iris pseudacorus) extract modulating
differentiation of osteoblasts and osteoclasts. Am J Chin Med. 2012, 40(6):1289-305.
PMID: 23227798
2) Fabre C, Dual inhibition of canonical and noncanonical NF-κB pathways
demonstrates significant antitumor activities in multiple myeloma. Clin Cancer Res.
2012, 18(17):4669-81. PMID: 22806876
3) Wu K, Dextromethorphan inhibits osteoclast differentiation by suppressing RANKLinduced nuclear factor-κB activation. Osteoporos Int. 2013, 24(8):2201-14. PMID:234002504) Kuo CH, Lung tumor associated dendritic cell-derived resistin promoted cancer
progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway.
Carcinogenesis. 2013, 34(11):2600-9. PMID: 23955539
5) Kanzaki H, The keap1/nrf2 protein axis plays a role in osteoclast differentiation by
regulating intracellular reactive oxygen species signaling. J Biol Chem. 2013,288(32):23009-20. PMID: 238013346) Moon

SJ, Temporal

differentialeffectsof proinflammatory cytokinesonosteoclastogenesis. Int J Mol Med. 2013, 31(4):769-77. PMID: 23403591
7) HaradaK,

Polyphosphate-MediatedInhibitionofTartrate-Resistant

AcidPhosphatase and Suppression of Bone Resorption of Osteoclasts. PLoS One. 2013,8(11): e78612. PMID: 24223830
8) Hokugo A, Equilibrium-dependent bisphosphonate interaction with crystalline bonemineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosisof the jaw in rats. Bone. 2013, 53:59-68. PMID: 23219943
9) Eda H, A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with theproteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple
myeloma model with resultant antimyeloma activity. Leukemia. 2014, 28(9):1892-901. PMID: 24518207
10) Orosa B, Lysophosphatidic acid receptor inhibition as a new multipronged treatment
for rheumatoid arthritis. Ann Rheum Dis. 2014, 73(1):298-305. PMID: 23486415
11) Kanzaki

H,

NuclearNrf2

induction

byproteintransduction

attenuates

osteoclastogenesis. Free Radic Biol Med. 2014, 77:239-48. PMID: 25224039
12) Sharma R, Caspase-2 maintains bone homeostasis by inducing apoptosis ofoxidatively-damaged osteoclasts. PLoS One. 2014, 9(4):e93696. PMID: 24691516
13) Hsieh CJ, Wedelolactone inhibits breast cancer-induced osteoclastogenesis bydecreasing Akt/mTOR signaling. Int J Oncol, 2015, 46(2):555-62. PMID: 25421824
14) Kloos B, Pasteurella multocida toxin- induced osteoclastogenesis requires mTORactivation. Cell Commun Signal. 2015, 13:40. PMID: 26369790
15) Mishima K, Lansoprazole Upregulates Polyubiquitination of the TNF ReceptorAssociatedFactor

6andFacilitates

Runx2-mediatedOsteoblastogenesis.

EBioMedicine. 2015, 2(12):2046-61. PMID: 26844285
16) Kim KW., Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis. Am JPathol. 2015, 185(11):3011-24. PMID: 26362732
17) Gohda J., HIV-1 replicates in human osteoclasts and enhances their differentiationin vitro. Retrovirology. 2015, 12, 12. PMID: 25809599
18) Tsai YM., Syringetin suppresses osteoclastogenesis mediated by osteoblasts inhuman lung adenocarcinoma. Oncol Rep, 2015, 34: 617-626.
19) Ishikawa S, Inductive Effect of Palmatine on Apoptosis in RAW 264.7 Cells. EvidBased Complement Alternat Med. 2016;2016:7262054
20) Wijekoon S, Chronological differential effects of pro-inflammatory cytokines onRANKL-inducedosteoclastdifferentiationofcanine

macrophages. J Vet Med Sci. 2017, 79(12):2030-2035.

bonemarrow-derived21) Maruyama K, Nociceptors Boost the Resolution of Fungal Osteoinflammation via theTRP Channel-CGRP-Jdp2 Axis. Cell Rep, 2017, 19(13):2730-2742.
22) Wijekoon HMS, Inhibitory effects of sodium pentosan polysulfate on formation andfunction of osteoclasts derived from canine bone marrow. BMC Vet Res. 2018,14(1):152.
23) Jin SH, Actin-binding LIM Protein 1 Regulates Receptor Activator of NF-κB LigandMediated Osteoclast Differentiation and Motility. BMB Rep. 2018 Jul;51(7):356-361.
24) Nishida M, S100A12 facilitates osteoclast differentiation from human monocytes.
PLoS One. 2018, 13(9):e0204140.
25) Ohnuma K, MicroRNA-124 inhibits TNF-α- and IL-6-induced osteoclastogenesis.
Rheumatol Int. 2019, 39(4):689-695.
26) Lee KA., Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis. ArthritisRes Ther, 2019, 21(1):283. PMID: 3183103827) Kumagai M, Fluorinated Kavalactone Inhibited RANKL-Induced Osteoclast
Differentiation of RAW264 Cells. Biol Pharm Bull. 2020, 43(5):898-903. PMID:32378565
28) Lee EJ, Coumarin Ameliorates Impaired Bone Turnover by Inhibiting the Formationof Advanced Glycation End Products in Diabetic Osteoblasts and Osteoclasts.
Biomolecules, 2020, 10(7):1052. PMID: 32679814
29) Na W., Aesculetin Inhibits Osteoclastic Bone Resorption through Blocking RuffledBorder Formation and Lysosomal Trafficking. Int J Mol Sci, 2020, 21(22):8581.
PMID: 33203061
30) Nishioku

T,(-)-Epigallocatechin-3-gallate

inhibits

RANKL-induced

osteoclastogenesis via downregulation of NFATc1 and suppression of HO-1-HMGB1RAGE pathway. Biomed Res. 2020, 41(6):269-277. PMID: 33268671

31) Park KH, Inhibitory Effect of Rosae Multiflorae Fructus Extracts on the Receptor
Activator of NF-κB Ligand-Induced Osteoclastogenesis through Modulation of P38and Ca 2+-Mediated Nuclear Factor of Activated T-Cells Cytoplasmic 1 Expression.
J Bone Metab. 2020, 27(1):53-63. PMID: 32190609
32) Wada S, Bach1 Inhibition Suppresses Osteoclastogenesis via Reduction of theSignaling via Reactive Oxygen Species by Reinforced Antioxidation. Front Cell Dev
Biol, 2020, 8:740. PMID: 3285085033) Jeong S, Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis byRegulating p38 and NF-κB Activation in RAW 264.7 Cells. Molecules, 2020,25(17):3908. PMID: 32867185
34) Lee EJ, Hydroxycoumarin Scopoletin Inhibits Bone Loss through Enhancing
Induction of Bone Turnover Markers in a Mouse Model of Type 2 Diabetes.
Biomedicines, 2021, 9(6):648. PMID: 34200167
35) Zhen G, An antibody against Siglec-15 promotes bone formation and fracture healing
by increasing TRAP + mononuclear cells and PDGF-BB secretion. Bone Res, 2021,9(1):47. PMID: 34719673
36) Haryati AH., Demethylbelamcandaquinone B from Marantodes pumilum var. alata(Blume) Kuntze inhibits osteoclast differentiation in RAW264.7 cells. Asian Pac J
Trop Biomed. 2021, 11(12): 535-542.
37) Cho E, Identification of Novel Genes for Cell Fusion during Osteoclast Formation.
Int J Mol Sci, 2022, 23(12):6421. PMID: 35742859
38) Hayashi C., miR-1260b inhibits periodontal bone loss by targeting ATF6β mediatedregulation of ER stress. Front Cell Dev Biol, 2022, 10:1061216. PMID: 36531939
39) Kelk P., Aggregatibacter actinomycetemcomitans Leukotoxin Activates the NLRP3Inflammasome and Cell-to-Cell Communication. Pathogens, 2022,11(2):159. PMID:3521510240) Wijekoon S., Pentosan polysulfate regulates hepcidin 1-facilitated formation andfunction of osteoclast derived from canine bone marrow. PLoS One, 2022,
17(3):e0265596. PMID: 3529923341) Okawa H., Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ)
revealed by targeted removal of legacy bisphosphonate from jawbone using
competing inert hydroxymethylene diphosphonate. Elife. 2022; 11: e76207. PMID:3601799542) Chen Q., Aberrant activation of TGF-β1 induces high bone turnover via Rho
GTPases-mediated cytoskeletal remodeling in Camurati-Engelmann disease. Front
Endocrinol (Lausanne). 2022; 13: 913979. PMID: 36325441
43) Su XD., Aster saponin A2 inhibits osteoclastogenesis through mitogen-activatedprotein kinase-c-Fos-NFATc1 signaling pathway. J Vet Sci, 2022, 23(4):e47. PMID:3569880644) Kang IH., Quantitative increase in T regulatory cells enhances bone remodeling inosteogenesis imperfecta. iScience. 2022, 25(9):104818. PMID: 36034228
45) Yoshimoto S., IL-6 Plays a Critical Role in Stromal Fibroblast RANKL Induction andConsequent O.steoclastogenesis in Ameloblastoma Progression. Lab Invest, 2023,103, 100023. PMID: 36748192
46) Ding M., Crucial Role of Lysine-Specific Histone Demethylase 1 in RANKL-MediatedOsteoclast Differentiation. Int J Mol Sci, 2023, 24(4):3605. PMID: 36835016
47) Blümke A., Comparison of osteoclast differentiation protocols from human induced
pluripotent stem cells of different tissue origins. Stem Cell Res Ther, 2023, 14(1):319.
PMID: 37936199
48) Omata Y., Essentiality of Nfatc1 short isoform in osteoclast differentiation and its
self-regulation. Sci Rep, 2023, 13(1):18797. PMID: 37914750
49) Jang

HY,Protaetia

brevitarsis

Extract

Attenuates

RANKL-Induced

Osteoclastogenesis by Inhibiting the JNK/NF-κB/PLCγ2 Signaling Pathway.
Nutrients. 2023, 15(14):3193. PMID: 37513611

50) Song J., A mixture of Pueraria lobata and Platycodon grandiflorum extracts
ameliorates RANKL-induced osteoclast differentiation and ovariectomy-inducedbone loss by regulating Src- PI3K-AKT and JNK/p38 signaling pathways. Heliyon,
2024, 10(2):e24842. PMID: 38312605